Literature DB >> 7306436

Metformin kinetics in healthy subjects and in patients with diabetes mellitus.

G T Tucker, C Casey, P J Phillips, H Connor, J D Ward, H F Woods.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7306436      PMCID： PMC1401849          DOI： 10.1111/j.1365-2125.1981.tb01206.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  IGPHARM: interactive graphic package for pharmacokinetic analysis.

Authors:  C Gomeni; R Gomeni
Journal:  Comput Biomed Res       Date:  1978-08

2.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

3.  [Absorption, distribution in the organism and elimination of metformin].

Authors:  R Beckmann
Journal:  Diabetologia       Date:  1969-10       Impact factor: 10.122

4.  Biguanides and lactic acidosis.

Authors:  P J Phillips; D W Thomas; P E Harding
Journal:  Br Med J       Date:  1977-01-22

5.  Epidemiology of adverse drug reactions to phenformin and metformin.

Authors:  U Bergman; G Boman; B E Wiholm
Journal:  Br Med J       Date:  1978-08-12

6.  Determination of metformin in biological samples.

Authors:  M S Lennard; C Casey; G T Tucker; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

7.  Accumulation in the peripheral compartment of a linear two-compartment open model.

Authors:  I Gonda; E S Harpur
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

8.  Pharmacokinetics of metformin after intravenous and oral administration to man.

Authors:  P J Pentikäinen; P J Neuvonen; A Penttilä
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

9.  [Biguanide-induced and - associated lactic acidosis: serum and tissue biguanide levels in hyperlactaemia and lactic acidosis (author's transl)].

Authors:  K Irsigler; H Kritz; H Regal; L Kaspar
Journal:  Wien Klin Wochenschr       Date:  1979-01-19       Impact factor: 1.704

10.  Disposition of metformin (N,N-dimethylbiguanide) in man.

Authors:  C R Sirtori; G Franceschini; M Galli-Kienle; G Cighetti; G Galli; A Bondioli; F Conti
Journal:  Clin Pharmacol Ther       Date:  1978-12       Impact factor: 6.875
View more
  130 in total

Review 1.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

Review 2.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

3.  Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus.

Authors:  Christophe Bardin; Estelle Nobecourt; Etienne Larger; François Chast; Jean-Marc Treluyer; Saik Urien
Journal:  Eur J Clin Pharmacol       Date:  2012-01-25       Impact factor: 2.953

4.  Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.

Authors:  Y H Choi; M G Lee
Journal:  Br J Pharmacol       Date:  2006-08-29       Impact factor: 8.739

5.  Steady-state pharmacokinetics of a novel extended-release metformin formulation.

Authors:  Peter Timmins; Steve Donahue; Jeff Meeker; Punit Marathe
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

6.  Metformin and the intestine.

Authors:  C J Bailey; C Wilcock; J H B Scarpello
Journal:  Diabetologia       Date:  2008-06-05       Impact factor: 10.122

7.  A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug.

Authors:  Mohammed M Alvi; Parnali Chatterjee
Journal:  AAPS PharmSciTech       Date:  2013-12-20       Impact factor: 3.246

8.  Metformin enhances insulin signalling in insulin-dependent and-independent pathways in insulin resistant muscle cells.

Authors:  Naresh Kumar; Chinmoy S Dey
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

9.  The Association between Metformin Therapy and Lactic Acidosis.

Authors:  Isabelle H S Kuan; Ruth L Savage; Stephen B Duffull; Robert J Walker; Daniel F B Wright
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

10.  Involvement of organic cation transporter 3 (Oct3/Slc22a3) in the bioavailability and pharmacokinetics of antidiabetic metformin in mice.

Authors:  Yoshiyuki Shirasaka; Nora Lee; Weibin Zha; David Wagner; Joanne Wang
Journal:  Drug Metab Pharmacokinet       Date:  2016-04-30       Impact factor: 3.614
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.